Ratliff, M.; Kim, H.; Qi, H.; Kim, M.; Ku, B.; Azorin, D.D.; Hausmann, D.; Khajuria, R.K.; Patel, A.; Maier, E.;
et al. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. Int. J. Mol. Sci. 2022, 23, 6572.
https://doi.org/10.3390/ijms23126572
AMA Style
Ratliff M, Kim H, Qi H, Kim M, Ku B, Azorin DD, Hausmann D, Khajuria RK, Patel A, Maier E,
et al. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. International Journal of Molecular Sciences. 2022; 23(12):6572.
https://doi.org/10.3390/ijms23126572
Chicago/Turabian Style
Ratliff, Miriam, Hichul Kim, Hao Qi, Minsung Kim, Bosung Ku, Daniel Dominguez Azorin, David Hausmann, Rajiv K. Khajuria, Areeba Patel, Elena Maier,
and et al. 2022. "Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma" International Journal of Molecular Sciences 23, no. 12: 6572.
https://doi.org/10.3390/ijms23126572
APA Style
Ratliff, M., Kim, H., Qi, H., Kim, M., Ku, B., Azorin, D. D., Hausmann, D., Khajuria, R. K., Patel, A., Maier, E., Cousin, L., Ogier, A., Sahm, F., Etminan, N., Bunse, L., Winkler, F., El-Khoury, V., Platten, M., & Kwon, Y. -J.
(2022). Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. International Journal of Molecular Sciences, 23(12), 6572.
https://doi.org/10.3390/ijms23126572
